The financing will support Adcendo’s ongoing advancement of its first-in-class and best-in-class ADC pipeline targeting cancers of high unmet medical need, including further clinical development of three main programmes.
Jeito Capital led the round, joined by new investors Vida Ventures, BPI France, and EIFO (Export and Investment Fund of Denmark).
Previous inve...